References:
[1]
Magalhães
T N C,Weiler M,Teixeira C V L,et al. Systemic Inflammation and
Multimodal Biomarkers in Amnestic Mild Cognitive Impairment and
Alzheimer’s Disease[J]. Molecular Neurobiology,2018,55(7):
5689-5697.
[2]
Shen
X,Niu L,Wang Y,et al. Inflammatory markers in Alzheimer’s disease and
mild cognitive impairment: a meta-analysis and systematic review of 170
studies[J]. Journal of Neurology, Neurosurgery &
Psychiatry,2019,90(5): 590-598.
[3]
Fang
Y,Du N,Xing L,et al. Evaluation of hippocampal volume and serum
brain-derived neurotrophic factor as potential diagnostic markers of
conversion from amnestic mild cognitive impairment to Alzheimer disease:
A STROBE-compliant article[J]. Medicine (Baltimore),2019, 98(30):
e16604.
[4]
Palmqvist
S,Janelidze S,Stomrud E.et al. Performance of Fully Automated Plasma
Assays as Screening Tests for Alzheimer Disease-Related-Amyloid
Status[J]. JAMA Neurol,2019,76(9): 1060-1069.